Overview

A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder

Status:
Completed

Trial end date:
2013-10-01

Target enrollment:

Participant gender:

Summary

This study will evaluate the efficacy of paliperidone palmitate compared with placebo in the delay of relapse of the symptoms of schizoaffective disorder. This study will also assess the safety and tolerability of paliperidone palmitate in patients with schizoaffective disorder.

Phase:

Phase 3

Details

Lead Sponsor:

Janssen Scientific Affairs, LLC

Treatments:

Paliperidone Palmitate